Cite
Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.
MLA
Dong, Biao, et al. “Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.” Biochemical Genetics, Jan. 2024, pp. 1–24. EBSCOhost, https://doi.org/10.1007/s10528-023-10625-0.
APA
Dong, B., Zhang, Y., Gao, H., Liu, J., & Li, J. (2024). Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma. Biochemical Genetics, 1–24. https://doi.org/10.1007/s10528-023-10625-0
Chicago
Dong, Biao, Yueshan Zhang, Han Gao, Jia Liu, and Jiankun Li. 2024. “Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.” Biochemical Genetics, January, 1–24. doi:10.1007/s10528-023-10625-0.